Senior US Soldier Based at NATO Headquarters Arrested on Suspicion of Helping RussiaNovember 11, 2026
Ava E. Davis on October 28, 2026 2:49 pm Silver leverage is strong here; beta cuts both ways though. Reply
Elizabeth Hernandez on October 28, 2026 2:49 pm Uranium names keep pushing higher—supply still tight into 2026. Reply
Noah Lopez on October 28, 2026 2:50 pm Silver leverage is strong here; beta cuts both ways though. Reply
Oliver P. Lee on October 28, 2026 2:50 pm I like the balance sheet here—less leverage than peers. Reply
Mary Rodriguez on October 28, 2026 2:51 pm Nice to see insider buying—usually a good signal in this space. Reply
Elijah Davis on October 28, 2026 2:52 pm Exploration results look promising, but permitting will be the key risk. Reply
Robert Lopez on October 28, 2026 2:54 pm Nice to see insider buying—usually a good signal in this space. Reply
Noah Garcia on October 28, 2026 2:56 pm I like the balance sheet here—less leverage than peers. Reply
Ava G. Davis on October 28, 2026 2:57 pm Interesting update on Domestic Attacks will Target Hospitals. Curious how the grades will trend next quarter. Reply
Elijah Y. Hernandez on October 28, 2026 2:57 pm The cost guidance is better than expected. If they deliver, the stock could rerate. Reply
James Brown on October 28, 2026 3:00 pm Nice to see insider buying—usually a good signal in this space. Reply
Noah Taylor on October 28, 2026 3:01 pm I like the balance sheet here—less leverage than peers. Reply
23 Comments
Silver leverage is strong here; beta cuts both ways though.
Uranium names keep pushing higher—supply still tight into 2026.
Silver leverage is strong here; beta cuts both ways though.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
I like the balance sheet here—less leverage than peers.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Nice to see insider buying—usually a good signal in this space.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Exploration results look promising, but permitting will be the key risk.
Good point. Watching costs and grades closely.
Nice to see insider buying—usually a good signal in this space.
Good point. Watching costs and grades closely.
I like the balance sheet here—less leverage than peers.
Interesting update on Domestic Attacks will Target Hospitals. Curious how the grades will trend next quarter.
The cost guidance is better than expected. If they deliver, the stock could rerate.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Nice to see insider buying—usually a good signal in this space.
I like the balance sheet here—less leverage than peers.
Good point. Watching costs and grades closely.